ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc (CRNX)

54.36
1.02
(1.91%)
Closed July 27 4:00PM
54.36
0.04
(0.07%)
After Hours: 6:40PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
54.36
Bid
52.34
Ask
56.54
Volume
541,345
53.20 Day's Range 55.06
15.76 52 Week Range 55.78
Market Cap
Previous Close
53.34
Open
54.24
Last Trade
10
@
55.44
Last Trade Time
Financial Volume
$ 29,335,622
VWAP
54.1903
Average Volume (3m)
968,513
Shares Outstanding
78,859,510
Dividend Yield
-
PE Ratio
-19.97
Earnings Per Share (EPS)
-2.72
Revenue
4.01M
Net Profit
-214.53M

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Crinetics Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRNX. The last closing price for Crinetics Pharmaceuticals was $53.34. Over the last year, Crinetics Pharmaceuticals shares have traded in a share price range of $ 15.76 to $ 55.78.

Crinetics Pharmaceuticals currently has 78,859,510 shares outstanding. The market capitalization of Crinetics Pharmaceuticals is $4.21 billion. Crinetics Pharmaceuticals has a price to earnings ratio (PE ratio) of -19.97.

CRNX Latest News

Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.422.6822818284952.9455.7852.0957169753.81375935CS
410.6924.47904740143.6755.7843.11102530449.47914007CS
126.8414.393939393947.5255.7841.0196851348.07664627CS
2616.6644.190981432437.755.7835.787127945.33049794CS
5235.79192.73021001618.5755.7815.76101774235.7081213CS
15634.36171.82055.7815.2355853729.66656584CS
26031.96142.67857142922.455.7810.6338366827.93241842CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

Your Recent History

Delayed Upgrade Clock